Risk of stroke in patients with inflammatory bowel disease: a systematic review and meta-analysis

被引:0
|
作者
Luo, Chao [1 ]
Liu, Lingpei [1 ]
Zhu, Di [1 ]
Ge, Zuanmin [1 ]
Chen, Yuehua [1 ]
Chen, Feng [2 ,3 ]
机构
[1] Zhejiang Univ, Affiliated Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Gen Practice,Sch Med, Jinhua 321000, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Neurosurg,Sch Med, Jinhua 321000, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Neurosurg,Sch Med, 365 Renmin East Rd, Jinhua 321000, Zhejiang, Peoples R China
关键词
Crohn's disease; Inflammatory bowel disease; Meta-analysis; Stroke; Ulcerative colitis; HEART-DISEASE; THERAPY;
D O I
10.1186/s12876-025-03702-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundCurrent studies suggest a potential link between inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), and cardiovascular diseases, such as stroke. This study aimed to assess the risk of stroke in IBD patients compared to general population.MethodsSystematic search was done in PubMed, Embase, CENTRAL, Scopus, and CINAHL databases for studies published till September 2023. Using a random-effects model, the hazard ratios (HRs) with 95% confidence intervals (CIs) for stroke occurrence were calculated. Subgroup analyses were done to estimate pooled HR with 95%CI for CD, UC, and overall IBD cases separately. Publication bias assessment was done by Begg's and Egger's tests.ResultsThirteen studies with 2,802,955 participants were included. IBD patients in general had significantly higher risk of stroke, with HR of 1.30 [95% CI 1.21-1.39]. Subgroup analysis demonstrated an HR of 1.35 [95% CI 1.22-1.49] for CD and 1.15 [95% CI 1.09-1.22] for UC. Substantial heterogeneity was detected across studies, with no substantial publication bias. Sensitivity analyses affirmed the stability of findings.ConclusionIBD in general, and Crohn's disease in particular are associated with significantly higher risk of stroke. Our findings further emphasize the importance of cardiovascular risk assessment and management strategies in IBD care.Protocol registrationPROSPERO, CRD42023470602.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Antidepressant treatment in inflammatory bowel disease: a systematic review and meta-analysis
    Weston, Frances
    Carter, Ben
    Powell, Nick
    Young, Allan H.
    Moulton, Calum D.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (07) : 850 - 860
  • [22] Risk of atrial fibrillation in patients with inflammatory bowel disease: A systematic review and meta-analysis
    Ke, Yangyang
    Zhu, Wengen
    Kaisaier, Wulamiding
    Chen, Yili
    IJC HEART & VASCULATURE, 2024, 55
  • [23] Predefined Diets in Patients with Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
    Comeche, Jose M.
    Gutierrez-Hervas, Ana
    Tuells, Jose
    Altavilla, Cesare
    Caballero, Pablo
    NUTRIENTS, 2021, 13 (01) : 1 - 22
  • [24] Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease
    Piovani, Daniele
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    Nikolopoulos, Georgios K.
    Bonovas, Stefanos
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (09) : 820 - 830
  • [25] Prevalence and risk factors of sexual dysfunction in patients with inflammatory bowel disease: systematic review and meta-analysis
    Wei, Shi
    Zhang, Jinzhi
    Zeng, Qishan
    Wu, Xinyao
    Gan, Huatian
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (09) : 2027 - 2038
  • [26] Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Lin, Hanyang
    Bai, Zhaohui
    Meng, Fanjun
    Wu, Yanyan
    Luo, Li
    Shukla, Akash
    Yoshida, Eric M.
    Guo, Xiaozhong
    Qi, Xingshun
    FRONTIERS IN MEDICINE, 2022, 8
  • [27] Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease
    Lu, M. J.
    Qiu, X. Y.
    Mao, X. Q.
    Li, X. T.
    Zhang, H. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (03) : 318 - 331
  • [28] Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis
    Kim, Jihoon
    Jung, Jae Hung
    Jo, Halim
    Kim, Myung Ha
    Kang, Dae Ryong
    Kim, Hee Man
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (12) : 1412 - 1421
  • [29] Abnormal platelet parameters in inflammatory bowel disease: a systematic review and meta-analysis
    Xu, Cheng
    Song, Zhen
    Hu, Li-ting
    Tong, Yi-heng
    Hu, Jing-yi
    Shen, Hong
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [30] Systematic review and meta-analysis of the role ofFaecalibacterium prausnitziialteration in inflammatory bowel disease
    Zhao, Hailan
    Xu, Haoming
    Chen, Shuzhen
    He, Jie
    Zhou, Youlian
    Nie, Yuqiang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (02) : 320 - 328